...
首页> 外文期刊>Molecular cancer therapeutics >Gramicidin A induces metabolic dysfunction and energy depletion leading to cell death in renal cell carcinoma cells
【24h】

Gramicidin A induces metabolic dysfunction and energy depletion leading to cell death in renal cell carcinoma cells

机译:Gramicidin A诱导肾功能癌细胞的代谢功能障碍和能量耗竭,导致细胞死亡

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Ionophores are lipid-soluble organic molecules that disrupt cellular transmembrane potential by rendering biologic membranes permeable to specific ions. They include mobile-carriers that complex with metal cations and channel-formers that insert into the membrane to form hydrophilic pores. Although mobile-carriers possess anticancer properties, investigations on channel-formers are limited. Here, we used the channelforming ionophore gramicidin A to study its effects on the growth and survival of renal cell carcinoma (RCC) cells. RCC is a histologically heterogeneous malignancy that is highly resistant to conventional treatments. We found that gramicidinAreduced the in vitro viability of severalRCCcell lines at submicromolar concentrations (all IC50 1.0 μmol/L). Gramicidin A exhibited similar toxicity in RCC cells regardless of histologic subtype or the expression of either the von Hippel-Lindau tumor suppressor gene or its downstream target, hypoxiainducible factor-1a. Gramicidin Adecreased cell viability equal to or greater than the mobile-carrier monensin depending on the cell line. Mechanistic examination revealed that gramicidin A blocks ATP generation by inhibiting oxidative phosphorylation and glycolysis, leading to cellular energy depletion and nonapoptotic cell death. Finally, gramicidin A effectively reduced the growth of RCC tumor xenografts in vivo. These results show a novel application of gramicidin A as a potential therapeutic agent for RCC therapy. Mol Cancer Ther; 12(11); 2296-307.
机译:离子载体是脂溶性有机分子,通过使生物膜可透过特定离子而破坏细胞跨膜电位。它们包括与金属阳离子络合的移动载体和插入膜中形成亲水孔的通道形成剂。尽管移动载体具有抗癌特性,但对通道形成剂的研究仍然有限。在这里,我们使用通道形成离子载体短杆菌肽A来研究其对肾细胞癌(RCC)细胞生长和存活的影响。 RCC是一种组织学上异质的恶性肿瘤,对常规治疗高度耐药。我们发现,gramicidinA在亚微摩尔浓度(所有IC50 <1.0μmol/ L)下降低了几种RCC细胞系的体外生存能力。不论组织学亚型还是von Hippel-Lindau抑癌基因或其下游靶标低氧诱导因子-1a的表达,Gramicidin A在RCC细胞中均表现出相似的毒性。 Gramicidin可降低等于或大于移动载体莫能菌素的细胞活力,具体取决于细胞系。机理检查表明,短杆菌肽A通过抑制氧化磷酸化和糖酵解来阻止ATP的产生,从而导致细胞能量消耗和非凋亡细胞死亡。最后,短杆菌肽A有效地减少了体内RCC肿瘤异种移植物的生长。这些结果显示出了大蒜素A作为RCC治疗的潜在治疗剂的新应用。分子癌疗法; 12(11); 2296-307。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号